Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             125 results found
no title author magazine year volume issue page(s) type
1 Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters? Salwan, Aaron J.
2018
7 p. 573-577
article
2 Acetazolamide and Cardiac Failure Cimolai, Nevio
2018
7 p. 649-650
article
3 Acid-Suppressive Therapy and Risk of Infections: Pros and Cons Fisher, Leon
2017
7 p. 587-624
article
4 Acid-Suppressive Therapy and Risk of Infections: Pros and Cons Fisher, Leon

7 p. 587-624
article
5 A Comparison of the Steady-State Pharmacokinetic and Pharmacodynamic Profiles of 100 and 200 U/mL Formulations of Ultra-Long-Acting Insulin Degludec Korsatko, Stefan
2013
7 p. 515-521
article
6 Acute Renal Failure, Ketoacidosis, and Urogenital Tract Infections with SGLT2 Inhibitors: Signal Detection Using a Japanese Spontaneous Reporting Database Katsuhara, Yukari

7 p. 645-652
article
7 Adherence to Antidepressants and Mortality in Elderly Patients with Cardiovascular Disease Biffi, Annalisa
2018
7 p. 593-602
article
8 Adverse Drug Reaction Profile of SGLT2 Inhibitor-Associated Diabetic Ketosis/Ketoacidosis in Singapore and their Precipitating Factors Limenta, Michael
2019
7 p. 683-690
article
9 Analysis of Clinical Predictors of Resolution of Sleep Disturbance Related to Frequent Nighttime Heartburn and Acid Regurgitation Symptoms in Individuals Taking Esomeprazole 20 mg or Placebo Johnson, David A.
2016
7 p. 531-538
article
10 An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA Bensimon, Arielle G.

7 p. 629-643
article
11 A Novel Once-Daily Fixed-Dose Combination of Memantine Extended Release and Donepezil for the Treatment of Moderate to Severe Alzheimer’s Disease: Two Phase I Studies in Healthy Volunteers Boinpally, Ramesh
2015
7 p. 427-435
article
12 An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease-19 (COVID-19) Das, Saibal

7 p. 591-601
article
13 A Phase 1 Study to Evaluate the Drug Interaction Between Islatravir (MK-8591) and Doravirine in Adults Without HIV Matthews, Randolph P.

7 p. 629-638
article
14 A Real-World Analysis of Prescribing Patterns and Non-persistence of Anti-TNFα Therapy for Inflammatory Bowel Disease Jang, Eun Jin
2019
7 p. 625-630
article
15 Association Between Migraine and Ischemic Cardio-Cerebrovascular Disease (CCVD) and Effects of Triptans and Ergotamine on the Risk of Ischemic CCVD in Patients with Migraine in the Korean NHIS-HEALS Cohort Kim, Yonghwan

7 p. 541-550
article
16 A Systematic Review of Neurocognitive Effects of Subanesthetic Doses of Intravenous Ketamine in Major Depressive Disorder, Post-Traumatic Stress Disorder, and Healthy Population Shiroma, Paulo R.

7 p. 549-566
article
17 Benzodiazepine Use, Misuse, and Harm at the Population Level in Canada: A Comprehensive Narrative Review of Data and Developments Since 1995 Murphy, Yoko
2016
7 p. 519-530
article
18 Blister-Packing of 2 mg Buprenorphine Monoproduct as a Patient-Centered Method of Microdosing for Buprenorphine Induction Accurso, Anthony J.

7 p. 663-664
article
19 Budesonide/Formoterol Maintenance and Reliever Therapy in Asian Patients (Aged ≥16 Years) with Asthma Vogelmeier, C.
2012
7 p. 439-449
article
20 Buprenorphine Microinduction: Logistical Barriers and the Need for Convergent Evidence De Aquino, Joao P.

7 p. 665
article
21 Clinical Pharmacokinetics of the Nicotinic Channel Modulator Dexmecamylamine (TC-5214) in Subjects with Various Degrees of Renal Impairment Alverlind, Sofie
2014
7 p. 457-465
article
22 Comment on ‘Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety’ Koren, Andrew

7 p. 659-660
article
23 Comparing the Effects of Sertraline with Duloxetine for Depression Severity and Symptoms: A Double-Blind, Randomized Controlled Trial Mowla, Arash
2016
7 p. 539-543
article
24 Comparison of Health Services Use Associated with Ziprasidone and Olanzapine among Schizophrenia and Bipolar Disorder Patients in the USA Jiang, Yawen
2014
7 p. 491-499
article
25 Comparison of Safety Profiles of New Oral Anticoagulants with Warfarin Using the Japanese Spontaneous Reporting Database Hosohata, Keiko
2019
7 p. 665-670
article
26 Correction to: Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials Song, Gwan Gyu
2019
7 p. 701
article
27 Correction to: Rifamycin SV MMX®: A Review in the Treatment of Traveller’s Diarrhoea Hoy, Sheridan M.
2019
7 p. 699
article
28 Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain Vennera, María del Carmen
2016
7 p. 567-578
article
29 Cost-Effectiveness of First-Line Nivolumab Plus Ipilimumab Combination Therapy in Advanced Non-Small-Cell Lung Cancer in Japan Mo, Xiuting

7 p. 599-609
article
30 Cost-Effectiveness of Fixed-Dose Combinations Therapies for Chronic Obstructive Pulmonary Disease Treatment Capel, Margarita
2018
7 p. 611-620
article
31 Current Clinical Trials on the Use of Ceftaroline in the Pediatric Population Corey, Adam
2017
7 p. 625-634
article
32 Current Clinical Trials on the Use of Ceftaroline in the Pediatric Population Corey, Adam

7 p. 625-634
article
33 Current Topics in Opioid Therapy for Pain Management: Addressing the Problem of Abuse Casty, Frank E.
2013
7 p. 459-468
article
34 Developmental Changes in Morphine Clearance Across the Entire Paediatric Age Range are Best Described by a Bodyweight-Dependent Exponent Model Wang, Chenguang
2013
7 p. 523-534
article
35 Discomfort from an Alkaline Formulation Delivered Subcutaneously in Humans Ward, W. Kenneth
2012
7 p. 433-438
article
36 Disease Burden, Early Discontinuation, and Healthcare Costs in Hepatitis C Patients with and without Chronic Kidney Disease Treated with Interferon-Free Direct-Acting Antiviral Regimens Puenpatom, Amy
2017
7 p. 687-697
article
37 Dose-Dependent Effect of Landiolol, a New Ultra-Short-Acting β1-Blocker, on Supraventricular Tachyarrhythmias in Postoperative Patients Taenaka, Nobuyuki
2013
7 p. 505-514
article
38 Dose Recommendations for Common Drugs in Patients with Liver Cirrhosis: A Systematic Literature Review Karsten Dafonte, Katharina

7 p. 475-502
article
39 Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand Bamrungsawad, Naruemon
2016
7 p. 557-566
article
40 Economic Evaluation of Posaconazole Versus Fluconazole or Itraconazole in the Prevention of Invasive Fungal Infection in High-Risk Neutropenic Patients in Sweden Lundberg, Johan
2014
7 p. 483-489
article
41 Effectiveness of an Intervention to Improve Management of COPD using the AUDIT Methodology: Results of the Neumo-Advance Study de Miguel-Díez, Javier
2019
7 p. 653-664
article
42 Effect of Atorvastatin on Haemostasis, Fibrinolysis and Inflammation in Normocholesterolaemic Patients with Coronary Artery Disease Walter, Thomas
2010
7 p. 453-460
article
43 Effect of Cytochrome P450 and ABCB1 Polymorphisms on Imatinib Pharmacokinetics After Single-Dose Administration to Healthy Subjects Pena, María Ángeles

7 p. 617-628
article
44 Effect of Omecamtiv Mecarbil on the Pharmacokinetics of Metformin, a Probe Substrate for MATE1/MATE2-K, in Healthy Subjects Trivedi, Ashit

7 p. 647-652
article
45 Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Liver Fat Mass and Body Composition in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus Arase, Yoshitaka
2019
7 p. 631-641
article
46 Effects of AZD0837, a Novel Direct Thrombin Inhibitor, on the Electrophysiological Properties of the Human Heart Walfridsson, Håkan
2010
7 p. 461-471
article
47 Efficacy and Safety of Naftifine Hydrochloride 2% Gel in Interdigital Tinea Pedis: A Phase III Randomised, Double-Blind, Parallel-Group, Active-Controlled Study in Indian Adult Patients Sinha, Shubhadeep D.

7 p. 565-574
article
48 Efficacy and Safety of Neoadjuvant Treatment with Bevacizumab, Liposomal Doxorubicin, Cyclophosphamide and Paclitaxel Combination in Locally/Regionally Advanced, HER2-Negative, Grade III at Premenopausal Status Breast Cancer: A Phase II Study Tampaki, Ekaterini C.
2018
7 p. 639-648
article
49 Efficacy of Interferon-Free Therapies for Chronic Hepatitis C: A Systematic Review of All Randomized Clinical Trials Ferreira, Vinicius L.
2017
7 p. 635-646
article
50 Elevations in Creatine Kinase are Not Related to the Choice or Dose of Statins in Patients Taking Colchicine 0.5 mg Daily: Insights from the LoDoCo2 Trial van Broekhoven, Amber

7 p. 575-577
article
51 Erratum to: Surfactants in Acute Respiratory Distress Syndrome in Infants and Children: Past, Present and Future Amigoni, Angela
2017
7 p. 711
article
52 Estimating the Product Lifecycle Value of Trastuzumab Based on Registry Data in Sweden Justo, Nahila

7 p. 529-540
article
53 Evaluation of Buprenorphine Dosage Adequacy in Opioid Receptor Agonist Substitution Therapy for Heroin Dependence D’Amore, Antonio
2012
7 p. 427-432
article
54 Evaluation of Pharmacokinetic and Pharmacodynamic Interactions when Lenalidomide is Co-administered with Warfarin in a Randomized Clinical Trial Setting Weiss, Daniel
2015
7 p. 455-461
article
55 Evaluation of the Pharmacokinetics and Pharmacodynamics of Prasugrel in Japanese Elderly Subjects Hasunuma, Tomoko
2017
7 p. 679-685
article
56 Exposure–Safety Response Relationship for Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir, and Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: Analysis of Data from Five Phase II and Six Phase III Studies Lin, Chih-Wei
2017
7 p. 647-657
article
57 Expression of Concern to: Fetal Safety of Dydrogesterone Exposure in the First Trimester of Pregnancy Koren, Gideon

7 p. 681
article
58 Fixed or Adjustable Maintenance-Dose Budesonide/Formoterol Compared with Fixed Maintenance-Dose Salmeterol/Fluticasone Propionate in Asthma Patients Aged ≥16 Years Aalbers, René
2010
7 p. 439-451
article
59 Guillain–Barré Syndrome Associated with COVID-19 Vaccines: A Perspective From Spontaneous Report Data Atzenhoffer, Marina

7 p. 581-592
article
60 Health Economic Analysis of Antiplatelet Therapy for Acute Coronary Syndromes in the Context of Five Eastern Asian Countries Wu, Bin
2018
7 p. 621-630
article
61 Impact of Anthracyclines on Diabetes Mellitus Development in B-Cell Lymphoma Patients: A Nationwide Population-based Study Teng, Chieh-Lin Jerry
2018
7 p. 603-610
article
62 Interventions and Strategies to Improve Oral Anticoagulant Use in Patients with Atrial Fibrillation: A Systematic Review of Systematic Reviews Ng, Siok Shen
2018
7 p. 579-591
article
63 Linking the Price of Cancer Drug Treatments to Their Clinical Value Gozzo, Lucia
2016
7 p. 579-589
article
64 Long Pulmonary Residence Time and Plasma Half-Life of Tiotropium: Implications for Pharmacokinetic Bioequivalence Studies Sharma, Ashish
2017
7 p. 705-707
article
65 Long-term Renal Effects of Tenofovir-Disoproxil-Fumarate in Vertically HIV-Infected Children, Adolescents, and Young Adults: A 132-Month Follow-Up Study Giacomet, Vania
2015
7 p. 419-426
article
66 Maintenance Therapy in HER2-Negative Metastatic Breast Cancer: A New Approach for an Old Concept Ciruelos, Eva
2019
7 p. 595-606
article
67 Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence Yeganeh Salehpour, Mahshid
2019
7 p. 607-624
article
68 New Oral Anticoagulants for Thromboprophylaxis in Patients with Cancer Receiving Chemotherapy: An Economic Evaluation in a Chinese Setting Du, Jiangyang

7 p. 653-663
article
69 Observational Study of Intravenous Lacosamide in Patients with Convulsive Versus Non-Convulsive Status Epilepticus Moreno Morales, Eros Yamel
2015
7 p. 463-469
article
70 Observational Study on Dipeptidyl Peptidase-4 Inhibitors: A Real-Life Analysis on 360 Patients from the ASL VCO Territory in Italy Saglietti, Giuseppe
2014
7 p. 513-519
article
71 Oral Cyclo-Oxygenase 2 Inhibitors versus Other Oral Analgesics for Acute Soft Tissue Injury Jones, Peter
2010
7 p. 419-437
article
72 Oral Teicoplanin as an Alternative First-Line Regimen in Clostridium difficile Infection in Elderly Patients: A Case Series Davido, Benjamin
2017
7 p. 699-703
article
73 Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with Osteoarthritis Brown, Mark T.

7 p. 551-563
article
74 Pharmacokinetic and Exposure–Response Analyses of Leuprolide Following Administration of Leuprolide Acetate 3-Month Depot Formulations to Children with Central Precocious Puberty Mostafa, Nael M.
2014
7 p. 441-448
article
75 Pharmacokinetics and Safety of Erenumab after a Single Subcutaneous Injection Dose in Healthy Chinese Subjects Shen, Qi

7 p. 623-630
article
76 Pharmacokinetics of a New Immediate-Release Methadone Tablet Formulation with Decreased In vitro Solubility Vinson, Robert K.
2012
7 p. 487-495
article
77 Pharmacokinetics of Anti-tuberculous Drugs Delivered Via Nasogastric Tube Feeding in a Critically Ill Patient: A Case Study Alsultan, Abdullah

7 p. 675-678
article
78 Pharmacokinetics of Extended-Release Dipyridamole following Administration through a Gastrostomy Tube Batista, Leonardo M.
2010
7 p. 483-488
article
79 Pharmacokinetic Study of Saxagliptin in Healthy Chinese Subjects Li, Haiyan
2012
7 p. 465-473
article
80 Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction Correale, Michele

7 p. 567-579
article
81 Phase 1 Study of the Effect of Icosapent Ethyl on Warfarin Pharmacokinetic and Anticoagulation Parameters Braeckman, Rene A.
2014
7 p. 449-456
article
82 Prehospital Adenosine Diphosphate Receptor Blocker Use, Culprit Artery Flow, and Mortality in STEMI: The MADDEC Study Hautamäki, Markus

7 p. 605-613
article
83 Preservative-Free Latanoprost Eye Drops in Patients with Primary Open-Angle Glaucoma/Ocular Hypertension Sanford, Mark
2014
7 p. 521-528
article
84 Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release Imanaka, Keiichiro
2014
7 p. 501-511
article
85 Real-world Performance of a New Strategy for Off-Label Use of Guselkumab in Moderate to Severe Psoriasis: Super-Responder Patients as the Epitome of Efficacy and Optimisation Herranz-Pinto, Pedro

7 p. 517-527
article
86 Real-world Prescription Pattern, Discontinuation and Costs of Ibrutinib-Naïve Patients with Chronic Lymphocytic Leukemia: An Italian Healthcare Administrative Database Analysis Ronconi, Giulia

7 p. 595-604
article
87 Recombinant Human C1 Esterase Inhibitor in the Management of Hereditary Angioedema Riedl, Marc
2015
7 p. 407-417
article
88 Relationship Between the Expression of O6-Methylguanine-DNA Methyltransferase (MGMT) and p53, and the Clinical Response in Metastatic Pancreatic Adenocarcinoma Treated with FOLFIRINOX Vitellius, Carole
2017
7 p. 669-677
article
89 Relative Bioavailability of Omecamtiv Mecarbil Pediatric Minitablet Formulations in Healthy Adult Subjects Trivedi, Ashit

7 p. 639-645
article
90 Response to “Acetazolamide and Cardiac Failure” Imiela, Tomasz
2018
7 p. 651
article
91 Response to “Comment on: Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety” Lee, Young R.

7 p. 661-662
article
92 Response to Sharma et al.: Long Pulmonary Residence Time and Plasma Half-Life of Tiotropium: Implications for Pharmacokinetic Bioequivalence Studies Algorta, Jaime
2017
7 p. 709-710
article
93 RETRACTED ​ARTICLE: Efficacy of Menatetrenone (Vitamin K2) against Non-Vertebral and Hip Fractures in Patients with Neurological Diseases Iwamoto, Jun
2009
7 p. 471-479
article
94 RETRACTED ARTICLE: Fetal Safety of Dydrogesterone Exposure in the First Trimester of Pregnancy Koren, Gideon

7 p. 679
article
95 Rifamycin SV MMX®: A Review in the Treatment of Traveller’s Diarrhoea Hoy, Sheridan M.

7 p. 691-697
article
96 Rifamycin SV MMX®: A Review in the Treatment of Traveller’s Diarrhoea Hoy, Sheridan M.

7 p. 691-697
article
97 Safety and Clinical Pharmacokinetics of Nemonoxacin, a Novel Non-Fluorinated Quinolone, in Healthy Chinese Volunteers Following Single and Multiple Oral Doses Guo, Beining
2012
7 p. 475-486
article
98 Safety and Pharmacokinetics of PSD502 in Healthy Chinese Male and Female Volunteers: Two Randomized, Double-Blind, Placebo-Controlled, Phase I Trials Wang, Fangfang

7 p. 503-515
article
99 Safety and Tolerability of an Olmesartan Medoxomil-Based Regimen in Patients with Stage 1 Hypertension Chrysant, Steven G.
2010
7 p. 473-482
article
100 Safety and Tolerability of an SQ-Standardized GRAss ALlergy Immunotherapy Tablet (GRAZAX®) in a Real-Life Setting for Three Consecutive Seasons — The GRAAL Trial Wessel, François
2012
7 p. 451-463
article
101 Safety, Pharmacokinetics, and Pharmacogenetics of Single-Dose Teriflunomide Sodium and Leflunomide in Healthy Chinese Subjects Yao, Xueting
2019
7 p. 643-651
article
102 Safety, Tolerability, and Pharmacokinetics of SUVN-G3031, a Novel Histamine-3 Receptor Inverse Agonist for the Treatment of Narcolepsy, in Healthy Human Subjects Following Single and Multiple Oral Doses Nirogi, Ramakrishna

7 p. 603-615
article
103 Safety, Tolerability, and Pharmacokinetics of Suvorexant: A Randomized Rising-Dose Trial in Healthy Men Yee, Ka Lai
2018
7 p. 631-638
article
104 Safety, Tolerability and Pharmacokinetics of Yimitasvir Phosphate Capsule, a Novel Oral Hepatitis C Virus NS5A Inhibitor, in Healthy Chinese Volunteers Zhao, Nan
2019
7 p. 671-681
article
105 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Inhaled Doses of Umeclidinium in Healthy Subjects: Two Randomized Studies Cahn, Anthony
2013
7 p. 477-488
article
106 Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Heart Failure Events in Patients with Type 2 Diabetes Mellitus: A Cost Per Outcome Analysis Arbel, Ronen

7 p. 665-669
article
107 Spontaneous and Immune Checkpoint Inhibitor-Induced Autoimmune Diseases: Analysis of Temporal Information by Using the Japanese Adverse Drug Event Report Database Ogawa, Keiko

7 p. 615-627
article
108 Steady-State Pharmacokinetics of Darunavir/Ritonavir and Pitavastatin when Co-administered to Healthy Adult Volunteers Yu, Christine Y.
2014
7 p. 475-482
article
109 Steady-State Pharmacokinetics of Darunavir/Ritonavir and Pitavastatin when Co-administered to Healthy Adult Volunteers Yu, Christine Y.

7 p. 475-482
article
110 Successful Empirical Antifungal Therapy of Intravenous Itraconazole with Pharmacokinetic Evidence in Pediatric Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation Kim, Hyery
2015
7 p. 437-446
article
111 Successful Intravenous Thrombolysis and Endovascular Treatment for Acute Ischemic Stroke in a Patient Pretreated with Ticagrelor: A Case Report and Literature Review Rizzo, Federica

7 p. 653-657
article
112 Switching from a Free Association of Perindopril/Amlodipine to a Fixed-Dose Combination: Increased Antihypertensive Efficacy and Tolerability Hatalova, Katarina
2016
7 p. 591-598
article
113 Systematic Review of the Economic Evaluation of Sodium–Glucose Cotransporter-2 Inhibitors Used as Treatment in Patients with Heart Failure Nam, Kyungae

7 p. 463-474
article
114 Temporal Trends in Grade 3/4 Adverse Events and Associated Costs of Nivolumab Plus Cabozantinib Versus Sunitinib for Previously Untreated Advanced Renal Cell Carcinoma Geynisman, Daniel M.

7 p. 611-622
article
115 The Cerebrospinal Fluid Distribution of Postoperatively Administred Dexketoprofen and Etoricoxib and Their Effect on Pain and Inflammatory Markers in Patients Undergoing Hip Arthroplasty Piirainen, Annika
2016
7 p. 545-555
article
116 The Effect of Moderate Hepatic Impairment on the Pharmacokinetics of Ipragliflozin, a Novel Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor Zhang, Wenhui
2013
7 p. 489-496
article
117 The Effect of Rifampin on the Pharmacokinetics of Edoxaban in Healthy Adults Mendell, Jeanne
2015
7 p. 447-453
article
118 The Effect of Single and Multiple Doses of Rifampin on the Pharmacokinetics of Doravirine in Healthy Subjects Yee, Ka Lai
2017
7 p. 659-667
article
119 Thromboembolic Events While Taking Direct Oral Anticoagulants: An Analysis of Post-market WHO Database Reports from 2012 to 2020 Mitrovic, Darko

7 p. 593-598
article
120 Tolerability and Pharmacokinetics of Lobeglitazone, a Novel Peroxisome Proliferator-Activated Receptor-γ Agonist, After a Single Oral Administration in Healthy Female Subjects Park, Min Kyu
2014
7 p. 467-474
article
121 Translating Benzodiazepine Utilization Data into Meaningful Population Exposure: Integration of Two Metrics for Improved Reporting Brandt, Jaden
2018
7 p. 565-572
article
122 Treatment of Morton Neuroma with Botulinum Toxin A: A Pilot Study Climent, José M.
2013
7 p. 497-503
article
123 Treatment of Severe Hypertriglyceridemia-Induced Acute Pancreatitis with Subcutaneous Insulin: Case Report Lee, Jeonghun

7 p. 671-674
article
124 Twenty-Four-Hour Ambulatory Blood Pressure Reduction with a Perindopril/Amlodipine Fixed-Dose Combination Nagy, Viktor L.
2013
7 p. 469-476
article
125 Vortioxetine versus Duloxetine in the Treatment of Patients with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials Li, Guangjian
2016
7 p. 509-517
article
                             125 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands